Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs113448118 | chr7:1108954 | G/A | 0.000262 | 173 | 25.87 | 24.95 | 49.58 | KM Plot |
PCPG | rs11344831 | chr3:53092279 | TC/T | 7.28E-6 | 174 | 11.78 | 26.92 | 25.28 | KM Plot |
PCPG | rs1134510 | chr16:85222004 | C/T | 5.1E-9 | 173 | 25.6 | 23.83 | 15 | KM Plot |
PCPG | rs11345496 | chr8:126182340 | CT/C | 0.000275 | 178 | 25.77 | 25.53 | 4.17 | KM Plot |
PCPG | rs113455787 | chr21:38454445 | A/G | 9.4E-9 | 176 | 25.08 | 25.63 | 3.83 | KM Plot |
PCPG | rs113476208 | chr16:89590168 | T/TATCTC | 0.000269 | 177 | 27.6 | 25.53 | 19.25 | KM Plot |
PCPG | rs113557319 | chr22:50215987 | T/G | 0.000162 | 176 | 25.67 | 24.23 | 15.18 | KM Plot |
PCPG | rs11356431 | chr8:6731881 | TA/T | 7.25E-6 | 177 | 13.27 | 18.7 | 27.33 | KM Plot |
PCPG | rs113570538 | chr21:38561918 | G/A | 9.76E-9 | 176 | 24.85 | 25.87 | 3.83 | KM Plot |
PCPG | rs113575180 | chr3:53131043 | G/C | 8.54E-6 | 175 | 25.4 | 22.83 | 11.78 | KM Plot |
PCPG | rs1135886 | chr14:74526912 | G/A | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs113592127 | chr17:1440593 | G/A | 1.14E-5 | 178 | 24.7 | 26.73 | 25.17 | KM Plot |
PCPG | rs11360152 | chr13:37654752 | AC/A | 0.000287 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1136070 | chr16:1751935 | C/T | 0.000453 | 177 | 25.53 | 19.3 | 6.1 | KM Plot |
PCPG | rs11361027 | chr12:69009747 | AT/A | 1.33E-7 | 172 | 14.4 | 28.87 | 22.63 | KM Plot |